Cutting edge ai company gedicube and cyclomics sign binding loi to join forces and position themselves at the forefront of the global liquid biopsy marketplace

The combined companies aim to disrupt cancer diagnosis and treatment through early disease and recurrence detection, prediction of response to treatment, and personalized therapy.

RENB Ratings Summary

RENB Quant Ranking